17 completed, 5 unknown, 3 recruiting, 3 terminated. 32 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 32 | Completed 17, Unknown 5, Recruiting 3, Terminated 3, Not yet recruiting 2, Suspended 1, Withdrawn 1 |
Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index Lorazepam 1 mg, Placebo - Delirium Confusional State | Phase 4 | Not yet recruiting | University Hospital, Basel, Switzerland | 260 | 2027-03-01 | 2026-02-27 |
| HPV Vaccine Reduced Dose Gardasil-9, Lidocaine injection, Lorazepam - HPV | Phase 4 | Recruiting | Emory University | 100 | 2025-08-06 | 2026-08-31 |
| Computational Assessment of GABA Receptor Modulation in PTSD Lorazepam 1 mg tablet, Placebo tablet - Stress Disorders, Post-Traumatic | Phase 4 | Recruiting | VA Office of Research and Development | 150 | 2025-07-01 | 2026-06-16 |
| Ketamine for Sedation in Severe Traumatic Brain Injury Ketamine with propofol, Standard of Care propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam - Severe Traumatic Brain Injury, Intracranial Hypertension | Phase 4 | Suspended | Henry M. Jackson Foundation for the Advancement of Military Medicine | 50 | 2024-09-23 | 2025-07-14 |
| A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems Mianserin, Lorazepam - Depression | Phase 4 | Unknown | Zhenghui YI | 300 | 2024-07-01 | 2024-06-27 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression Lorazepam, Placebo - Depression, Anxiety, Fear | Phase 4 | Recruiting | Laureate Institute for Brain Research, Inc. | 165 | 2023-11-08 | 2025-10-31 |
| Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder | Phase 4 | Unknown | Temple University | 32 | 2023-07-01 | 2023-10-23 |
| Multimodal Analgesia Effect on Post Surgical Patient Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product - Obesity, Morbid, Surgery | Phase 4 | Completed | University of California, Davis | 60 | 2021-01-20 | 2026-09-14 |
| Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit Phenobarbital, Lorazepam - Alcohol Withdrawal, Alcohol Withdrawal Delirium | Phase 4 | Unknown | OSF Healthcare System | 142 | 2020-07-06 | 2020-10-08 |
| Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder | Phase 4 | Completed | University of Michigan | 143 | 2020-01-16 | 2026-06-17 |
| Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine Ketamine, Phenobarbital, Lorazepam - Alcohol Withdrawal Syndrome | Phase 4 | Withdrawn | Santa Barbara Cottage Hospital | 2019-04-12 | 2019-09-19 | |
| Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation Haloperidol + lorazepam, Loxapine - Agitation,Psychomotor, Haloperidol Causing Adverse Effects in Therapeutic Use | Phase 4 | Terminated | University of Arkansas | 2 | 2017-09-30 | 2018-06-11 |
| Assessment of Valproate on Ethanol Withdrawal Valproate, Lorazepam - Alcohol Dependence, Alcohol Withdrawal Syndrome | Phase 4 | Terminated | CAMC Health System | 3 | 2017-07-11 | 2026-08-18 |
| Oral Sedation During Cervical Dilator Placement Oxycodone and Lorazepam (Active Comparator), Placebo Comparator - Oral Sedation and Cervical Dilator Pain | Phase 4 | Completed | Johns Hopkins University | 27 | 2017-06-28 | 2020-03-30 |
| Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome Physostigmine, Lorazepam - Anticholinergics Toxicity | Phase 4 | Completed | University of Colorado, Denver | 19 | 2017-03-30 | 2021-08-23 |
| Gabapentin for Alcohol Withdrawal Syndrome Gabapentin, Benzodiazepines, Divalproex Sodium - Alcohol Withdrawal Syndrome | Phase 4 | Completed | Mayo Clinic | 88 | 2017-02-01 | 2022-03-24 |
| A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise Venlafaxine XR, Aerobic Exercise, Lorazepam - Depression, Depressive Disorder, Major | Phase 4 | Completed | Kirk Erickson, PhD | 31 | 2015-03-01 | 2018-05-23 |
| Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest Propofol, Lorazepam - Hypothermia, Cardiac Arrest | Phase 4 | Unknown | Far Eastern Memorial Hospital | 30 | 2013-08-01 | 2016-03-29 |
| Characterizing and Predicting Drug Effects on Cognition Lorazepam, Placebo, Topiramate 100mg - Cognitive Deficits | Phase 4 | Completed | University of Minnesota | 60 | 2013-07-01 | 2019-12-17 |
Showing 20 of 32. Sign in to see all of them.
Anxiety Disorders (4) · Depression (4) · Alcoholism (3) · Psychomotor Agitation (3) · Bipolar Disorder (2) · Generalized Anxiety Disorder (2) · Psychotic Disorders (2) · Schizophrenia (2) · Agnosia (1) · Alcohol Withdrawal Delirium (1) · Brain Injuries, Traumatic (1) · Cognition Disorders (1) · Confusion (1) · Depressive Disorder (1) · Depressive Disorder, Major (1)
Alexza Pharmaceuticals, Inc. (1) · CAMC Health System (1) · Elizabeth Micks (1) · Emory University (1) · Erasmus Medical Center (1) · Far Eastern Memorial Hospital (1) · GlaxoSmithKline (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Hospital Universitari de Bellvitge (1) · Johns Hopkins University (1) · Kirk Erickson, PhD (1) · Laureate Institute for Brain Research, Inc. (1) · Mayo Clinic (1) · Nathan Kline Institute for Psychiatric Research (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)
United States (22) · Netherlands (2) · Spain (2) · Argentina (1) · Austria (1) · China (1) · Costa Rica (1) · Croatia (1) · Czechia (1) · Finland (1) · Greece (1) · India (1) · Indonesia (1) · Lithuania (1) · Mexico (1)
Audis Bethea, PharmD, BCPS (1) · Barbara Jachniewicz, MSN, CRNFA, (1) · Bhagat Aulakh, MD (1) · Bradley Dengler, MD (1) · Carolyn Sufrin (1) · Elizabeth Micks, MD (1) · Erin Scherer, PhD (1) · George M Simpson, MD (1) · George S Wang, MD (1) · Jessica K Lee, MD (1) · Jonathan R Howlett, MD (1) · Kirk Erickson, PhD (1) · Maria Ironside, DPhil (1) · Markus Klimek, MD, PhD (1)
PMID 16785215, PMID 21040558, PMID 23090523, PMID 23635914, PMID 24351233, PMID 27022468, PMID 27282374, PMID 30797651, PMID 32297992, PMID 37469099
K23AA000222 (1), K24AA016555 (1), R01MH059142 (1), R01MH118634 (1), R01MH132565 (1)